|
|
 Previous Article | Table of Contents | Next Article 
Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's
lymphoma by two-color fluorescence in situ hybridization
P Mathew, WG Sanger, DD Weisenburger, M Valentine, V Valentine, D Pickering, C Higgins, M Hess, X Cui, DK Srivastava and SW Morris
Department of Pediatrics, Medical College of Ohio, Toledo, USA.
The non-Hodgkin's lymphoma (NHL) subset commonly referred to as large cell
lymphoma (LCL) has historically been characterized by it's marked
cytological, immunological, and clinical heterogeneity. One potential
defining feature of these lymphomas, the t(2;5)(p23;q35), occurs in 25% to
30% of anaplastic LCLs and is also found in cases with diffuse large cell
or immunoblastic morphology. We recently identified nucleophosmin (NPM) and
anaplastic lymphoma kinase (ALK) as the genes on chromosomes 5 and 2,
respectively, that are juxtaposed by this translocation. To provide a
complementary approach to the use of classical cytogenetics or polymerase
chain reaction-based methods for the detection of this abnormality, we have
developed a two-color fluorescent in situ hybridization (FISH) assay for
the t(2;5) that may be used for the analysis of both interphase nuclei and
metaphase chromosomes. Three overlapping chromosome 5 cosmid clones located
immediately centromeric to the NPM gene locus and an ALK P1 clone located
telomeric to the chromosome 2 breakpoint were labeled with digoxigenin or
biotin, respectively, and used to visualize the derivative chromosome 5
produced by the t(2;5), evident as juxtaposed or overlapping red and green
fluorescent signals. This NPM-ALK FISH assay was initially validated by
analysis of a series of cytogenetically characterized cell lines, with the
presence of the der(5) chromosome showed specifically only in those lines
known to contain the t(2;5). The assay was then applied in a blinded
fashion to a series of eight cytogenetically t(2;5)-positive clinical
specimens and seven known t(2;5)-negative cases, including three NHL and
four Hodgkin's disease biopsy samples. Whereas the t(2;5)-negative cases
were negative by FISH, all eight t(2;5)-positive cases were positive. One
additional case, initially thought to be positive for the translocation by
cytogenetics, was proven to not be a classic t(2;5) by interphase and
metaphase FISH. These data indicate that the FISH assay described is a
highly specific and rapid test that should prove to be a useful adjunct to
the currently available methods for detection of the t(2;5).
Volume 89,
Issue 5,
pp. 1678-1685,
03/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. A. Rizvi, A. M. Evens, M. S. Tallman, B. P. Nelson, and S. T. Rosen
T-cell non-Hodgkin lymphoma
Blood,
February 15, 2006;
107(4):
1255 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. De Paepe, M. Baens, H. van Krieken, B. Verhasselt, M. Stul, A. Simons, B. Poppe, G. Laureys, P. Brons, P. Vandenberghe, et al.
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
Blood,
October 1, 2003;
102(7):
2638 - 2641.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Debiec-Rychter, R. Croes, R. De Vos, P. Marynen, T. Roskams, A. Hagemeijer, R. Lombaerts, and R. Sciot
Complex Genomic Rearrangement of ALK Loci Associated with Integrated Human Epstein-Barr Virus in a Post-Transplant Myogenic Liver Tumor
Am. J. Pathol.,
September 1, 2003;
163(3):
913 - 922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Maes, V. Vanhentenrijk, I. Wlodarska, J. Cools, B. Peeters, P. Marynen, and C. De Wolf-Peeters
The NPM-ALK and the ATIC-ALK Fusion Genes Can Be Detected in Non-Neoplastic Cells
Am. J. Pathol.,
June 1, 2001;
158(6):
2185 - 2193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Greenland, N Dastugue, C Touriol, L Lamant, G Delsol, and P Brousset
Anaplastic large cell lymphoma with the t(2;5)(p23;q35) NPM/ALK chromosomal translocation and duplication of the short arm of the non-translocated chromosome 2 involving the full length of the ALK gene
J. Clin. Pathol.,
February 1, 2001;
54(2):
152 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Stein, H.-D. Foss, H. Durkop, T. Marafioti, G. Delsol, K. Pulford, S. Pileri, and B. Falini
CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
Blood,
December 1, 2000;
96(12):
3681 - 3695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Jaju, O. A. Haas, M. Neat, J. Harbott, V. Saha, J. Boultwood, J. M. Brown, H. Pirc-Danoewinata, B. W. Krings, U. Muller, et al.
A New Recurrent Translocation, t(5;11)(q35;p15.5), Associated With del(5q) in Childhood Acute Myeloid Leukemia
Blood,
July 15, 1999;
94(2):
773 - 780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rosenwald, G. Ott, K. Pulford, T. Katzenberger, J. Kuhl, J. Kalla, M. M. Ott, D. Y. Mason, and H. K. Muller-Hermelink
t(1;2)(q21;p23) and t(2;3)(p23;q21): Two Novel Variant Translocations of the t(2;5)(p23;q35) in Anaplastic Large Cell Lymphoma
Blood,
July 1, 1999;
94(1):
362 - 364.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Dave, M. M. Hess, D. L. Pickering, D. H. Zaleski, A. L. Pfeifer, D. D. Weisenburger, J. O. Armitage, and W. G. Sanger
Rearrangements of Chromosome Band 1p36 in Non-Hodgkin's Lymphoma
Clin. Cancer Res.,
June 1, 1999;
5(6):
1401 - 1409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Wlodarska, C. De Wolf-Peeters, B. Falini, G. Verhoef, S. W. Morris, A. Hagemeijer, and H. Van denBerghe
The Cryptic inv(2)(p23q35) Defines a New Molecular Genetic Subtype of ALK-Positive Anaplastic Large-Cell Lymphoma
Blood,
October 15, 1998;
92(8):
2688 - 2695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
